CEFTIZOXIME;(6-R,7-R)-7-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO]-3-CEPHEM-4-CARBOXYLIC-ACID
Compound with spectra: 1 NMR
![CEFTIZOXIME;(6-R,7-R)-7-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO]-3-CEPHEM-4-CARBOXYLIC-ACID](/api/compound/HiKNczUj81W.png?ph=true&h=300&w=458 "CEFTIZOXIME;(6-R,7-R)-7-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-METHOXYIMINOACETAMIDO]-3-CEPHEM-4-CARBOXYLIC-ACID")
| SpectraBase Compound ID | HiKNczUj81W |
|---|---|
| InChI | InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1 |
| InChIKey | NNULBSISHYWZJU-LLKWHZGFSA-N |
| Mol Weight | 383.4 g/mol |
| Molecular Formula | C13H13N5O5S2 |
| Exact Mass | 383.035811 g/mol |
| Enantiomer InChIKey | NNULBSISHYWZJU-CHIKPUOMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
IMPURITY-III;(4-R-S,6-R,7-R)-7-[(Z)-2-(2-AMINO-4-THIAZOLYL)-2-(METHOXYIMINO)ACETAMIDO]-3,4-DIHYDRO-3-CEPHEM-4-CARBOXYLIC-ACID;
Cephalosporin C
(7R)-3-(acetoxymethyl)-7-[(5-amino-6-hydroxy-6-keto-hexanoyl)amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
sodium 3-(acetoxymethyl)-7-[(5-ammonio-6-keto-6-oxido-hexanoyl)amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
7-(5-Amino-5-carboxy-pentanoylamido)-cephalosporanic acid, anion
7-(2-[2]Thienyl-acetamido)-desacetoxy-3'-methylthio-cephalosporanic acid, anion
7-(Phenyl-[formylamino]-acetamido)-desacetoxy-cephalosporanic acid
7-(2-[2]Thienyl-acetamido)-desacetyl-cephalosporanic acid, anion
7-(Phenyl-aminoacetamido)-desacetoxy-cephalosporanic anion
Cephalexin hydrate
| Title | Journal or Book | Year |
|---|---|---|
| Structural identification and characterization of impurities in ceftizoxime sodium | Journal of Pharmaceutical and Biomedical Analysis | 2007 |